Castle Biosciences, Inc. (CSTL)
USD 26.52
(-5.76%)
USD 26.52
(-5.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 219.78 Million | 137.03 Million | 94.08 Million | 62.64 Million | 51.86 Million | 22.78 Million |
| Cost of Revenue | 44.98 Million | 32 Million | 15.82 Million | 9.68 Million | 7.31 Million | 5.29 Million |
| Gross Profit | 174.8 Million | 105.03 Million | 78.26 Million | 52.96 Million | 44.55 Million | 17.48 Million |
| Operating Expenses | 242.78 Million | 196.17 Million | 118.34 Million | 59.5 Million | 37.22 Million | 21.32 Million |
| Selling, General and Administrative Expenses | 180.15 Million | 143 Million | 86.73 Million | 48.13 Million | 29.84 Million | 16.47 Million |
| Research and Development Expenses | 53.61 Million | 44.9 Million | 29.64 Million | 13.25 Million | 7.38 Million | 4.85 Million |
| Other Expenses | 9.01 Million | 8.26 Million | 1.95 Million | -1.88 Million | -2.93 Million | -272.41 Thousand |
| Cost and Expenses | 287.76 Million | 228.18 Million | 134.16 Million | 69.19 Million | 44.53 Million | 26.62 Million |
| Operating Income | -67.97 Million | -91.14 Million | -40.07 Million | -6.54 Million | 4.7 Million | -3.83 Million |
| Interest Expense | 11 Thousand | 17 Thousand | 1000.00 | 2.63 Million | 4.57 Million | 2.27 Million |
| Income Tax Expense | 101 Thousand | -1.76 Million | -8.72 Million | 84 Thousand | 72 Thousand | 8606.00 |
| Earnings before Tax | -57.36 Million | -68.9 Million | -40.01 Million | -10.2 Million | 5.34 Million | -6.35 Million |
| Net Income | -57.46 Million | -67.13 Million | -31.29 Million | -10.28 Million | 5.27 Million | -6.36 Million |
| Earnings Per Share Basic | -2.14 | -2.58 | -1.24 | -0.54 | 0.35 | -0.60 |
| Earnings Per Share Diluted | -2.14 | -2.58 | -1.24 | -0.54 | -0.21 | -0.60 |
| Weighted Average Shares Outstanding | 26.8 Million | 26.05 Million | 25.13 Million | 18.92 Million | 8.58 Million | 10.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.8 Million | 26.05 Million | 25.13 Million | 18.92 Million | 8.65 Million | 10.65 Million |
| Gross Margin | 0.80 | 0.77 | 0.83 | 0.85 | 0.86 | 0.77 |
| EBIT Margin | -0.20 | -0.56 | -0.39 | -0.09 | 0.10 | -0.17 |
| Profit Margin | -0.26 | -0.49 | -0.33 | -0.16 | 0.10 | -0.28 |
| EBITDA | -45.02 Million | -58.34 Million | -36.6 Million | -7.09 Million | 7.68 Million | -3.76 Million |
| Earnings Before Tax Margin | -0.31 | -0.67 | -0.43 | -0.10 | 0.09 | -0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 85.78 Million | 87 Million | 72.97 Million | 219.78 Million | 66.12 Million | 61.49 Million |
| Cost of Revenue | 15.6 Million | 17.23 Million | 16.57 Million | 55.55 Million | 15.09 Million | 11.31 Million |
| Gross Profit | 70.17 Million | 69.77 Million | 56.39 Million | 164.23 Million | 51.02 Million | 50.17 Million |
| Operating Expenses | 65.09 Million | 64.76 Million | 61.86 Million | 232.21 Million | 56.68 Million | 59.81 Million |
| Selling, General and Administrative Expenses | 50.49 Million | 50.7 Million | 48.41 Million | - | 43.77 Million | 44.61 Million |
| Research and Development Expenses | 12.32 Million | 14.05 Million | 13.45 Million | - | 12.91 Million | 12.92 Million |
| Other Expenses | 2.27 Million | 2.24 Million | 2.24 Million | 9.01 Million | 2.27 Million | 2.27 Million |
| Cost and Expenses | 80.7 Million | 81.99 Million | 78.44 Million | 287.76 Million | 71.77 Million | 71.13 Million |
| Operating Income | 5.07 Million | 5.01 Million | -5.47 Million | -67.97 Million | -5.65 Million | -9.64 Million |
| Interest Expense | -201 Thousand | 270 Thousand | 14 Thousand | 11 Thousand | 2000.00 | 2000.00 |
| Income Tax Expense | 6.01 Million | -1.03 Million | 45 Thousand | 101 Thousand | 39 Thousand | 32 Thousand |
| Earnings before Tax | 8.28 Million | 7.88 Million | -2.48 Million | -57.36 Million | -2.54 Million | -6.87 Million |
| Net Income | 2.26 Million | 8.92 Million | -2.53 Million | -57.46 Million | -2.58 Million | -6.9 Million |
| Earnings Per Share Basic | 0.08 | 0.32 | -0.09 | - | -0.10 | -0.26 |
| Earnings Per Share Diluted | 0.08 | 0.31 | -0.09 | - | -0.10 | -0.26 |
| Weighted Average Shares Outstanding | 27.84 Million | 27.64 Million | 27.48 Million | 26.8 Million | 27.03 Million | 26.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.4 Million | 28.73 Million | 27.48 Million | 26.8 Million | 27.03 Million | 26.83 Million |
| Gross Margin | 0.82 | 0.80 | 0.77 | 0.75 | 0.77 | 0.82 |
| EBIT Margin | 0.06 | 0.10 | -0.03 | - | -0.04 | -0.06 |
| Profit Margin | 0.03 | 0.10 | -0.03 | -0.26 | -0.04 | -0.11 |
| EBITDA | 5.07 Million | 8.35 Million | -2.13 Million | - | -2.43 Million | -3.69 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | -0.07 | -0.31 | -0.09 | -0.16 |
AREC
BALY
TPZ
QIIK
SADHNANIQ
QC7